Study Examining Tailored Anti-Platelet Heart Medication After Coronary Stent Receives Grant
University Health Network (UHN)Researchers at the Peter Munk Cardiac Centre, with expertise running large clinical trials, and at Mayo Clinic, are leading the Tailored Antiplatelet Therapy to Lessen Outcomes after Percutaneous Coronary Intervention (TAILOR-PCI) study. This study has received $7 million in additional funding from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).